BBI Life Sciences Corporation reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenue of RMB 253,193,000 compared to RMB 219,988,000 a year ago. Operating profit was RMB 17,681,000 compared to RMB 44,813,000 a year ago.

Profit before income tax was RMB 47,273,000 compared to RMB 49,576,000 a year ago. Total profit attributable to the equity shareholders of the company was RMB 33,290,000 compared to RMB 40,249,000 a year ago. Basic and diluted earnings per share was RMB 0.084 compared to RMB 0.102 a year ago.

Net cash generated from operating activities was RMB 50,355,000 compared to RMB 61,046,000 a year ago. The expenditure of purchasing intangible assets, namely computer software was RMB 2.7 million, while the expenditure of purchasing property, plant and equipment and of construction in process amounted to RMB 16.26 million.